0.589
price down icon1.95%   -0.0117
after-market After Hours: .57 -0.019 -3.23%
loading

Matinas Biopharma Holdings Inc Stock (MTNB) Latest News

pulisher
Feb 13, 2025

Matinas Biopharma Announces Agreement For The Acquisition Of Preferred Stock And Appointment Of Dr. Robin L. Smith To The Board Of Directors - Marketscreener.com

Feb 13, 2025
pulisher
Feb 13, 2025

Matinas BioPharma Announces Agreement for the Acquisition - GlobeNewswire

Feb 13, 2025
pulisher
Feb 13, 2025

Biotech Deal Alert: Matinas BioPharma Lands Critical $3.3M Investment While Strengthening Leadership - StockTitan

Feb 13, 2025
pulisher
Feb 12, 2025

Matinas BioPharma announces board member retirement - MSN

Feb 12, 2025
pulisher
Feb 11, 2025

Matinas BioPharma announces board member retirement By Investing.com - Investing.com South Africa

Feb 11, 2025
pulisher
Feb 09, 2025

Matinas BioPharma Holdings, Inc. to Host Earnings Call - ACCESS Newswire

Feb 09, 2025
pulisher
Feb 07, 2025

Matinas Biopharma Appoints Evelyn D’An as Director and Audit Committee Chair - Armenian Reporter

Feb 07, 2025
pulisher
Feb 07, 2025

Matinas BioPharma Appoints Evelyn D’An to Board - citybiz

Feb 07, 2025
pulisher
Feb 07, 2025

Matinas BioPharma Holdings, Inc. Appoints Evelyn D?An to Board of Directors as an Independent Director and Chair of the Audit Committee - Marketscreener.com

Feb 07, 2025
pulisher
Feb 07, 2025

Matinas Biopharma Appoints Evelyn D'An To Board Of Directors As Audit Committee Chair - Marketscreener.com

Feb 07, 2025
pulisher
Feb 07, 2025

Matinas BioPharma Appoints Evelyn D'An to Board of Directors as Audit Committee Chair - The Manila Times

Feb 07, 2025
pulisher
Feb 07, 2025

Matinas BioPharma Appoints Evelyn D’An to Board of Directors as Audit Committee Chair - GlobeNewswire

Feb 07, 2025
pulisher
Jan 25, 2025

Matinas BioPharma announces board member resignation - MSN

Jan 25, 2025
pulisher
Jan 25, 2025

Matinas BioPharma announces board member resignation By Investing.com - Investing.com South Africa

Jan 25, 2025
pulisher
Jan 25, 2025

Matinas Biopharma Holdings, Inc. Announces Resignation of James S. Scibetta from Board and Audit and Compensation Committees - Marketscreener.com

Jan 25, 2025
pulisher
Jan 24, 2025

111 Equity Group Increases Stake In Matinas Biopharma Holdings - citybiz

Jan 24, 2025
pulisher
Jan 24, 2025

111 Equity ups stake in Matinas Biopharma Holdings - Investing.com

Jan 24, 2025
pulisher
Jan 24, 2025

Activist Investor 111 Equity Takes 5.17% Stake in Matinas BioPharma, Seeks Value Creation - StockTitan

Jan 24, 2025
pulisher
Jan 12, 2025

**Matinas BioPharma Receives Notice of Noncompliance from NYSE American** - Defense World

Jan 12, 2025
pulisher
Jan 10, 2025

Matinas BioPharma Receives NYSE Noncompliance Notice - GlobeNewswire

Jan 10, 2025
pulisher
Jan 10, 2025

Matinas BioPharma Receives NYSE American Noncompliance Notice Over Delayed Annual Meeting - StockTitan

Jan 10, 2025
pulisher
Jan 05, 2025

State Street Corp Has $54,000 Stock Position in Matinas Biopharma Holdings, Inc. (NYSE:MTNB) - Defense World

Jan 05, 2025
pulisher
Dec 30, 2024

MTNB stock touches 52-week low at $0.5 amid sharp annual decline - Investing.com

Dec 30, 2024
pulisher
Dec 28, 2024

Matinas Biopharma (NYSE:MTNB) Shares Down 1.3% – What’s Next? - Defense World

Dec 28, 2024
pulisher
Nov 29, 2024

Matinas Biopharma Holdings, Inc. Announces Resignation of Kathryn Penkus Corzo from Board, Compensation and Nominating and Corporate Governance Committees - Marketscreener.com

Nov 29, 2024
pulisher
Nov 23, 2024

Matinas BioPharma Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 23, 2024
pulisher
Nov 22, 2024

MTNB (Matinas BioPharma Holdings) EPS (Diluted) : $-4.79 (TTM As of Sep. 2024) - GuruFocus.com

Nov 22, 2024
pulisher
Nov 04, 2024

Maxim Group Reiterates Hold Rating for Matinas BioPharma (NYSEAMERICAN:MTNB) - Defense World

Nov 04, 2024
pulisher
Nov 02, 2024

MTNBMatinas BioPharma Holdings, Inc. Latest Stock News & Market Updates - StockTitan

Nov 02, 2024
pulisher
Nov 01, 2024

Matinas BioPharma plunges as deal for lead asset falls apart - MSN

Nov 01, 2024
pulisher
Oct 31, 2024

Matinas BioPharma mulls wind-down as antifungal therapy deal falls through - Pharmaceutical Technology

Oct 31, 2024
pulisher
Oct 31, 2024

Matinas BioPharma stock falls on strategic options (MTNB:NYSE) - Seeking Alpha

Oct 31, 2024
pulisher
Oct 31, 2024

Nasdaq Down Over 200 Points; Microsoft Shares Fall After Q1 Results - Benzinga

Oct 31, 2024
pulisher
Oct 31, 2024

Matinas BioPharma Announces the Termination of MAT2203 Partnership Negotiations and Implements Immediate Workforce Reduction - The Manila Times

Oct 31, 2024
pulisher
Oct 31, 2024

Matinas BioPharma Announces the Termination of MAT2203 - GlobeNewswire

Oct 31, 2024
pulisher
Oct 31, 2024

Crude Oil Gains 1%; Meta Shares Fall Following Q3 Results - Benzinga

Oct 31, 2024
pulisher
Oct 30, 2024

MTNB stock touches 52-week low at $2.87 amid market challenges - Investing.com Canada

Oct 30, 2024
pulisher
Oct 30, 2024

Richmond pharma firm Kaléo appoints new chief development officer - The Business Journals

Oct 30, 2024
pulisher
Oct 29, 2024

MTNB stock touches 52-week low at $2.87 amid market challenges By Investing.com - Investing.com South Africa

Oct 29, 2024
pulisher
Oct 25, 2024

Highbridge Capital Management's Strategic Acquisition in Matinas BioPharma - GuruFocus.com

Oct 25, 2024
$74.40
price up icon 0.53%
$22.96
price up icon 2.04%
$33.69
price down icon 0.33%
$357.50
price down icon 0.20%
$110.97
price down icon 5.14%
biotechnology ONC
$259.70
price up icon 0.47%
Cap:     |  Volume (24h):